AAAAAA
Results:
1-15
|
Results: 15
Authors:
Demharter, J
Muller, P
Wagner, T
Schlimok, G
Haude, K
Bohndorf, K
Citation: J. Demharter et al., Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas, EUR RADIOL, 11(2), 2001, pp. 276-283
Authors:
Weckermann, D
Muller, P
Wawroschek, F
Harzmann, R
Riethmuller, G
Schlimok, G
Citation: D. Weckermann et al., Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: Detection and prognostic value, J UROL, 166(2), 2001, pp. 699-704
Authors:
Muller, P
Schlimok, G
Citation: P. Muller et G. Schlimok, Development and use of antiepithelial antibodies in solid tumors, INTERNIST, 42(6), 2001, pp. 827
Authors:
Schulze, R
Schulze, M
Salomon-Dani, A
Weihprecht, H
Bohndorf, K
Arnholdt, H
Schlimok, G
Citation: R. Schulze et al., Metasttic angiosarcoma of the right atrium during cyclosporin and prednisone immunosuppression after kidney transplantation, INTERNIST, 42(1), 2001, pp. 119-123
Authors:
Braun, S
Schlimok, G
Heumos, I
Schaller, G
Riethdorf, L
Riethmuller, C
Pantel, K
Citation: S. Braun et al., erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients, CANCER RES, 61(5), 2001, pp. 1890-1895
Authors:
Hempel, D
Muller, P
Oruzio, D
Behr, W
Brockmeyer, C
Wochner, M
Ehnle, S
Riethmuller, G
Schlimok, G
Citation: D. Hempel et al., Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells, CYTOTHERAPY, 2(4), 2000, pp. 287-295
Authors:
Muller, P
Schlimok, G
Citation: P. Muller et G. Schlimok, Bone marrow "micrometastases" of epithelial tumors: detection and clinicalrelevance, J CANC RES, 126(11), 2000, pp. 607-618
Authors:
Braun, S
Schlimok, G
Pantel, K
Citation: S. Braun et al., Bone marrow metastases in breast cancer - Reply, N ENG J MED, 343(8), 2000, pp. 578-578
Authors:
Braun, S
Pantel, K
Muller, P
Janni, W
Hepp, F
Kentenich, CRM
Gastroph, S
Wischnik, A
Dimpfl, T
Kindermann, G
Riethmuller, G
Schlimok, G
Citation: S. Braun et al., Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer., N ENG J MED, 342(8), 2000, pp. 525-533
Authors:
Fauser, AA
Fellhauer, M
Hoffmann, M
Link, H
Schlimok, G
Gralla, RJ
Citation: Aa. Fauser et al., Guidelines for anti-emetic therapy: Acute emesis, EUR J CANC, 35(3), 1999, pp. 361-370
Authors:
Krauter, J
Ganser, A
Bergmann, L
Raghavachar, A
Hoelzer, D
Lubbert, M
Schlimok, G
Arnold, R
Kirchner, H
Port, M
Heil, G
Citation: J. Krauter et al., Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML, ANN HEMATOL, 78(6), 1999, pp. 265-269
Authors:
Weckermann, D
Muller, P
Wawroschek, F
Krawczak, G
Riethmuller, G
Schlimok, G
Citation: D. Weckermann et al., Micrometastases of bone marrow in localized prostate cancer: Correlation with established risk factors, J CL ONCOL, 17(11), 1999, pp. 3438-3443
Authors:
Offner, S
Schmaus, W
Witter, K
Baretton, GB
Schlimok, G
Passlick, B
Riethmuller, G
Pantel, K
Citation: S. Offner et al., p53 gene mutations are not required for early dissemination of cancer cells, P NAS US, 96(12), 1999, pp. 6942-6946
Authors:
Schlimok, G
Citation: G. Schlimok, Monoclonal antibodies in colorectal cancer, INTERNIST, 40(3), 1999, pp. 317-318
Authors:
Hempel, D
Muller, P
Dani, J
Bluthgen, A
Bolte, H
Wagner, T
Knopfle, E
Schlimok, G
Citation: D. Hempel et al., Cardiogenic shock as primary symptom of high-grade malignant lymphoblasticT-cell non-Hodgkin's lymphoma of the mediastinum, INTERNIST, 40(11), 1999, pp. 1216-1220
Risultati:
1-15
|